Filing search / Context Therapeutics Inc. / "Reputation"

424B3

CNTX Context Therapeutics Inc.

12 Apr 22

Prospectus supplement

4:14pm

liable for harm caused to patients; the product may become less competitive; and our reputation may suffer. Any of these events could prevent us … relationships we may establish in the future are not effective and successful, it may damage our reputation and business prospects, delay or prevent

POS AM

CNTX Context Therapeutics Inc.

4 Apr 22

Prospectus update (post-effective amendment)

5:08pm

and held liable for harm caused to patients; the product may become less competitive; and our reputation may suffer. Any of these events could … or strategic relationships we may establish in the future are not effective and successful, it may damage our reputation and business prospects, delay

10-K

hg0ezf0c

23 Mar 22

Annual report

4:17pm

8-K

EX-99.2

5pp 9tmq146ji06phb2j

5 Jan 22

Context Therapeutics® Strengthens Research & Development Team

4:04pm

424B4

v1sg8x0trjaphymr7t6l

17 Dec 21

Prospectus supplement with pricing info

8:00am

424B4

chetj9yg61v4qy

20 Oct 21

Prospectus supplement with pricing info

5:05pm

S-1

x35fovfz7pryk29bgz5

27 May 21

IPO registration

5:28pm

S-1

EX-10.12

mc8jdp0uu1exl5cwe510

27 May 21

IPO registration

5:28pm

DRS/A

d84e8x 11pcky8pw

3 May 21

Draft registration statement (amended)

12:00am

DRS

0qox28mp9 oh

22 Mar 21

Draft registration statement

12:00am